LLY - Eli Lilly and Company - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LLY is currently covered by 16 analysts with an average price target of $1168.41. This is a potential upside of $126.62 (12.15%) from yesterday's end of day stock price of $1041.79.

Eli Lilly and Company's activity chart (see below) currently has 696 price targets and 489 ratings on display. The stock rating distribution of LLY is 92.11% BUY, 2.63% SELL and 5.26% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.71% with an average time for these price targets to be met of 279.59 days.

Highest price target for LLY is $1500, Lowest price target is $830, average price target is $1097.14.

Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 24-Nov-2025. First documented stock forecast 11-Nov-2013.

Currently out of the existing stock ratings of LLY, 35 are a BUY (92.11%), 1 are a SELL (2.63%), 2 are a HOLD (5.26%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$1290

$214.53 (19.95%)

$1171

23 days ago
(24-Nov-2025)

33/38 (86.84%)

$219.84 (20.54%)

201

Buy

$1150

$74.53 (6.93%)

$1050

29 days ago
(18-Nov-2025)

30/31 (96.77%)

$119.95 (11.65%)

278

Buy

$1165

$89.53 (8.32%)

$885

1 months 4 days ago
(13-Nov-2025)

47/48 (97.92%)

$176.38 (17.84%)

120

Buy

$1500

$424.53 (39.47%)

$1190

1 months 5 days ago
(12-Nov-2025)

1/4 (25%)

$511.38 (51.73%)

437

Buy

$1080

$4.53 (0.42%)

$895

1 months 7 days ago
(10-Nov-2025)

7/8 (87.5%)

$155.63 (16.84%)

138

Show more analysts

Please expand the browser size to see the chart

What is LLY (Eli Lilly and Company) average time for price targets to be met?

On average it took 279.59 days on average for the stock forecasts to be realized with a an average price target met ratio 92.71

Which analyst has the current highest performing score on LLY (Eli Lilly and Company) with a proven track record?

SRIKRIPA DEVARAKONDA

Which analyst has the most public recommendations on LLY (Eli Lilly and Company)?

Srikripa Devarakonda works at TRUIST and has 2 price targets and 5 ratings on LLY

Which analyst is the currently most bullish on LLY (Eli Lilly and Company)?

Peter Verdult with highest potential upside - $424.53

Which analyst is the currently most reserved on LLY (Eli Lilly and Company)?

Marc Goodman with lowest potential downside - -$990.47

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?